• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于代码的特发性肺纤维化诊断算法。病例验证和改进。

Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case Validation and Improvement.

机构信息

1 Department of Medicine and.

2 Department of Radiology and.

出版信息

Ann Am Thorac Soc. 2017 Jun;14(6):880-887. doi: 10.1513/AnnalsATS.201610-764OC.

DOI:10.1513/AnnalsATS.201610-764OC
PMID:28355518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5566307/
Abstract

RATIONALE

Population-based studies of idiopathic pulmonary fibrosis (IPF) in the United States have been limited by reliance on diagnostic code-based algorithms that lack clinical validation.

OBJECTIVES

To validate a well-accepted International Classification of Diseases, Ninth Revision, code-based algorithm for IPF using patient-level information and to develop a modified algorithm for IPF with enhanced predictive value.

METHODS

The traditional IPF algorithm was used to identify potential cases of IPF in the Kaiser Permanente Northern California adult population from 2000 to 2014. Incidence and prevalence were determined overall and by age, sex, and race/ethnicity. A validation subset of cases (n = 150) underwent expert medical record and chest computed tomography review. A modified IPF algorithm was then derived and validated to optimize positive predictive value.

RESULTS

From 2000 to 2014, the traditional IPF algorithm identified 2,608 cases among 5,389,627 at-risk adults in the Kaiser Permanente Northern California population. Annual incidence was 6.8/100,000 person-years (95% confidence interval [CI], 6.1-7.7) and was higher in patients with older age, male sex, and white race. The positive predictive value of the IPF algorithm was only 42.2% (95% CI, 30.6 to 54.6%); sensitivity was 55.6% (95% CI, 21.2 to 86.3%). The corrected incidence was estimated at 5.6/100,000 person-years (95% CI, 2.6-10.3). A modified IPF algorithm had improved positive predictive value but reduced sensitivity compared with the traditional algorithm.

CONCLUSIONS

A well-accepted International Classification of Diseases, Ninth Revision, code-based IPF algorithm performs poorly, falsely classifying many non-IPF cases as IPF and missing a substantial proportion of IPF cases. A modification of the IPF algorithm may be useful for future population-based studies of IPF.

摘要

背景

美国基于人群的特发性肺纤维化(IPF)研究受到仅依赖缺乏临床验证的诊断代码算法的限制。

目的

使用患者水平信息验证一种广泛接受的国际疾病分类,第九修订版(ICD-9)IPF 代码算法,并开发一种具有增强预测值的改良 IPF 算法。

方法

该研究使用传统的 IPF 算法在 2000 年至 2014 年期间从 Kaiser Permanente 北加利福尼亚州成年人群中确定潜在的 IPF 病例。总体上以及按年龄、性别和种族/族裔确定发病率和患病率。然后对 150 例病例进行专家病历和胸部计算机断层扫描回顾。然后得出并验证改良的 IPF 算法,以优化阳性预测值。

结果

2000 年至 2014 年,传统的 IPF 算法在 Kaiser Permanente 北加利福尼亚州的高危成人中识别出 2608 例病例。发病率为 6.8/100000 人年(95%置信区间[CI],6.1-7.7),年龄较大、男性和白人患者发病率更高。IPF 算法的阳性预测值仅为 42.2%(95%CI,30.6-54.6%);敏感性为 55.6%(95%CI,21.2-86.3%)。校正后的发病率估计为 5.6/100000 人年(95%CI,2.6-10.3)。与传统算法相比,改良的 IPF 算法具有更高的阳性预测值,但敏感性降低。

结论

一种广泛接受的 ICD-9 代码 IPF 算法性能不佳,错误地将许多非 IPF 病例归类为 IPF,并且漏诊了相当比例的 IPF 病例。IPF 算法的修改可能对未来的 IPF 基于人群的研究有用。

相似文献

1
Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case Validation and Improvement.基于代码的特发性肺纤维化诊断算法。病例验证和改进。
Ann Am Thorac Soc. 2017 Jun;14(6):880-887. doi: 10.1513/AnnalsATS.201610-764OC.
2
Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.美国自动索赔中的特发性肺纤维化。发病率、患病率和算法验证。
Am J Respir Crit Care Med. 2015 Nov 15;192(10):1200-7. doi: 10.1164/rccm.201504-0818OC.
3
Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old.美国 18-64 岁成年人特发性肺纤维化的发病率和患病率。
Eur Respir J. 2016 Jul;48(1):179-86. doi: 10.1183/13993003.01653-2015. Epub 2016 Apr 28.
4
Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care.特发性肺纤维化的流行病学:初级保健中的一项基于人群的研究。
Intern Emerg Med. 2020 Apr;15(3):437-445. doi: 10.1007/s11739-019-02195-0. Epub 2019 Sep 20.
5
Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada.加拿大全国数据中特发性肺纤维化的流行病学和生存情况。
Eur Respir J. 2016 Jul;48(1):187-95. doi: 10.1183/13993003.01504-2015. Epub 2016 May 26.
6
Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.利用美国健康索赔数据描述特发性肺纤维化的健康结局。
Respiration. 2020;99(2):108-118. doi: 10.1159/000504630. Epub 2020 Jan 24.
7
Incidence and prevalence of idiopathic interstitial pneumonia and idiopathic pulmonary fibrosis in Korea.韩国特发性间质性肺炎和特发性肺纤维化的发病率及患病率。
Int J Tuberc Lung Dis. 2016 Jul;20(7):978-84. doi: 10.5588/ijtld.16.0003.
8
Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older.美国65岁及以上医疗保险受益人中特发性肺纤维化的医疗保健利用情况及费用
Ann Am Thorac Soc. 2015 Jul;12(7):981-7. doi: 10.1513/AnnalsATS.201412-553OC.
9
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.美国 65 岁及以上医疗保险受益人群中的特发性肺纤维化:2001-2011 年的发病率、患病率和生存率。
Lancet Respir Med. 2014 Jul;2(7):566-72. doi: 10.1016/S2213-2600(14)70101-8. Epub 2014 May 27.
10
Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in Italy.意大利特发性肺纤维化(IPF)的发病率和患病率。
Sarcoidosis Vasc Diffuse Lung Dis. 2014 Oct 20;31(3):191-7.

引用本文的文献

1
Incidence and prevalence of idiopathic pulmonary fibrosis: a systematic literature review and meta-analysis.特发性肺纤维化的发病率和患病率:一项系统文献综述与荟萃分析。
BMC Pulm Med. 2025 Aug 7;25(1):378. doi: 10.1186/s12890-025-03836-1.
2
Shifting Trends in the Epidemiology and Management of Idiopathic Pulmonary Fibrosis in the Era of Evidence-Based Guidelines: a Nationwide Population Study.循证指南时代特发性肺纤维化流行病学和管理的变化趋势:一项全国性人群研究
J Epidemiol Glob Health. 2025 Mar 17;15(1):44. doi: 10.1007/s44197-025-00377-y.
3
The applications of CT with artificial intelligence in the prognostic model of idiopathic pulmonary fibrosis.人工智能 CT 在特发性肺纤维化预后模型中的应用。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241282538. doi: 10.1177/17534666241282538.
4
Differences in Health Care and Palliative Care Use at the End of Life: A Comparison Study Among Lung Cancer, COPD, and Idiopathic Pulmonary Fibrosis.临终时医疗保健与姑息治疗使用情况的差异:肺癌、慢性阻塞性肺疾病和特发性肺纤维化的比较研究
Chest. 2024 Dec;166(6):1487-1496. doi: 10.1016/j.chest.2024.08.018. Epub 2024 Aug 24.
5
Effect of Antifibrotic Use on Mortality in Patients with Idiopathic Pulmonary Fibrosis.抗纤维化药物治疗特发性肺纤维化患者的死亡率影响。
Ann Am Thorac Soc. 2024 Oct;21(10):1407-1415. doi: 10.1513/AnnalsATS.202312-1054OC.
6
The Impact of Chronic Comorbidities on Outcomes in Acute Exacerbations of Idiopathic Pulmonary Fibrosis.慢性合并症对特发性肺纤维化急性加重期预后的影响
Life (Basel). 2024 Jan 21;14(1):156. doi: 10.3390/life14010156.
7
Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database.日本慢性肺病患者肺动脉高压的患者和治疗概况:一项使用理赔数据库的队列研究
Pulm Ther. 2024 Mar;10(1):21-49. doi: 10.1007/s41030-023-00243-x. Epub 2023 Nov 11.
8
Uptake of Antifibrotics for Patients with Idiopathic Pulmonary Fibrosis: 2016-2022.特发性肺纤维化患者抗纤维化药物的使用情况:2016 - 2022年
Ann Am Thorac Soc. 2024 Jan;21(1):170-173. doi: 10.1513/AnnalsATS.202308-697RL.
9
Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review.全球间质性肺疾病的发病率和患病率:系统文献回顾。
BMJ Open Respir Res. 2023 Jun;10(1). doi: 10.1136/bmjresp-2022-001291.
10
Machine-Learning Algorithm to Improve Cohort Identification in Interstitial Lung Disease.用于改善间质性肺疾病队列识别的机器学习算法
Am J Respir Crit Care Med. 2023 May 15;207(10):1398-1401. doi: 10.1164/rccm.202211-2092LE.

本文引用的文献

1
Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old.美国 18-64 岁成年人特发性肺纤维化的发病率和患病率。
Eur Respir J. 2016 Jul;48(1):179-86. doi: 10.1183/13993003.01653-2015. Epub 2016 Apr 28.
2
Radiologic-pathologic discordance in biopsy-proven usual interstitial pneumonia.经活检证实的普通间质性肺炎中的放射病理学差异。
Eur Respir J. 2016 Apr;47(4):1189-97. doi: 10.1183/13993003.01680-2015. Epub 2016 Feb 25.
3
Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.美国自动索赔中的特发性肺纤维化。发病率、患病率和算法验证。
Am J Respir Crit Care Med. 2015 Nov 15;192(10):1200-7. doi: 10.1164/rccm.201504-0818OC.
4
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.特发性肺纤维化的全球发病率和死亡率:系统评价。
Eur Respir J. 2015 Sep;46(3):795-806. doi: 10.1183/09031936.00185114. Epub 2015 May 14.
5
CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis.可能的普通型间质性肺炎的CT扫描表现对组织学上的普通型间质性肺炎具有较高的预测价值。
Chest. 2015 Feb;147(2):450-459. doi: 10.1378/chest.14-0976.
6
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.美国 65 岁及以上医疗保险受益人群中的特发性肺纤维化:2001-2011 年的发病率、患病率和生存率。
Lancet Respir Med. 2014 Jul;2(7):566-72. doi: 10.1016/S2213-2600(14)70101-8. Epub 2014 May 27.
7
Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial.高分辨率 CT 诊断影像学无蜂窝肺表现或表现轻微的特发性肺纤维化患者:一项随机对照试验的二次分析。
Lancet Respir Med. 2014 Apr;2(4):277-84. doi: 10.1016/S2213-2600(14)70011-6. Epub 2014 Feb 18.
8
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.美国胸科学会/欧洲呼吸学会官方声明:特发性间质性肺炎的国际多学科分类的更新。
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48. doi: 10.1164/rccm.201308-1483ST.
9
Prevalence and prognosis of unclassifiable interstitial lung disease.无法分类的间质性肺疾病的患病率和预后。
Eur Respir J. 2013 Sep;42(3):750-7. doi: 10.1183/09031936.00131912. Epub 2012 Dec 6.
10
The rising incidence of idiopathic pulmonary fibrosis in the U.K.英国特发性肺纤维化发病率的上升
Thorax. 2011 Jun;66(6):462-7. doi: 10.1136/thx.2010.148031. Epub 2011 Apr 27.